The sequencing-based assay for transposase-accessible chromatin (ATAC-seq) (Buenrostro et al., 2013) was employed to tease out mechanisms used by ERK and CBP/p300 to reconfigure lung cancer epigenomes. This evidence concerns the gene MAPK1 and lung cancer.